{"organizations": [], "uuid": "8a251375e0e9223cccea47028e0a9a84a5cc0b0a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180306.html", "section_title": "Archive News &amp; Video for Tuesday, 06 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-us-fda-approves-first-tests-to-scr/brief-u-s-fda-approves-first-tests-to-screen-for-tickborne-parasite-in-whole-blood-plasma-idUSFWN1QO0R6", "country": "US", "domain_rank": 408, "title": "BRIEF-U.S. FDA Approves First Tests To Screen For Tickborne Parasite In Whole Blood & Plasma", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.798, "site_type": "news", "published": "2018-03-07T07:22:00.000+02:00", "replies_count": 0, "uuid": "8a251375e0e9223cccea47028e0a9a84a5cc0b0a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-us-fda-approves-first-tests-to-scr/brief-u-s-fda-approves-first-tests-to-screen-for-tickborne-parasite-in-whole-blood-plasma-idUSFWN1QO0R6", "ord_in_thread": 0, "title": "BRIEF-U.S. FDA Approves First Tests To Screen For Tickborne Parasite In Whole Blood & Plasma", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "babesia", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "u.s. food and drug administration", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "microti", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 6 (Reuters) - U.S. Food and Drug Administration:\n* U.S. FDA SAYS APPROVED THE IMUGEN BABESIA MICROTI ARRAYED FLUORESCENT IMMUNOASSAY FOR DETECTING ANTIBODIES TO BABESIA MICROTI IN HUMAN PLASMA SAMPLES\n* U.S. FDA SAYS APPROVED THE IMUGEN BABESIA MICROTI NUCLEIC ACID TEST FOR DETECTING B. MICROTI DNA IN HUMAN WHOLE BLOOD SAMPLES\n* U.S. FDA SAYS APPROVAL OF THE IMUGEN BABESIA MICROTI AFIA AND NAT TESTS WAS GRANTED TO OXFORD IMMUNOTEC INC Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-07T07:22:00.000+02:00", "crawled": "2018-03-07T19:21:18.006+02:00", "highlightTitle": ""}